A case of delayed detection of vertical transmission of HIV-1 due to maternal therapy with long-acting injectable cabotegravir plus rilpivirine
We report on a 4-month-old infant with delayed HIV-1 diagnosis after maternal antiretroviral therapy with long-acting injectable cabotegravir plus rilpivirine (LA-CAB/RPV) in the third trimester. Prolonged viral suppression in HIV-infected infants exposed to maternal LA-CAB/RPV may necessitate molecular testing beyond three months of age to exclude infection.
Authors
- Nikolai Menner
- Irena Rohr
- Cornelia Feiterna‐Sperling (ORCID: https://orcid.org/0000-0003-4171-1098)
- Renate Krüger (ORCID: https://orcid.org/0000-0001-8728-9385)
- Victor Max Corman
- E Albers
- Martin Obermeier (ORCID: https://orcid.org/0000-0003-2511-9553)
- Christoph Bührer (ORCID: https://orcid.org/0000-0002-9950-414X)
- Katharina Weizsäcker
Institutions
- Deutsches Herzzentrum der Charité (DE)
- Vivantes Klinikum (DE)
- Helios Hospital Berlin-Buch (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2026-04-25
- DOI
- https://doi.org/10.1093/cid/ciag290
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00